Found: 3
Select item for more details and to access through your institution.
Evaluation of exclusive enteral nutrition and corticosteroid induction treatment in new-onset moderate-to-severe luminal paediatric Crohn's disease.
- Published in:
- European Journal of Pediatrics, 2022, v. 181, n. 8, p. 3055, doi. 10.1007/s00431-022-04496-7
- By:
- Publication type:
- Article
Randomised clinical trial: First‐line infliximab biosimilar is cost‐effective compared to conventional treatment in paediatric Crohn's disease.
- Published in:
- Alimentary Pharmacology & Therapeutics, 2024, v. 59, n. 12, p. 1510, doi. 10.1111/apt.18000
- By:
- Publication type:
- Article
Serum Immune Profiling in Paediatric Crohn's Disease Demonstrates Stronger Immune Modulation With First-Line Infliximab Than Conventional Therapy and Pre-Treatment Profiles Predict Clinical Response to Both Treatments.
- Published in:
- Journal of Crohn's & Colitis, 2023, v. 17, n. 8, p. 1262, doi. 10.1093/ecco-jcc/jjad049
- By:
- Publication type:
- Article